Literature DB >> 3910495

The alpha cell response to glucose change during perfusion of anti-insulin serum in pancreas isolated from normal rats.

H Maruyama, M Tominaga, G Bolli, L Orci, R H Unger.   

Abstract

To determine the effect of neutralization of endogenous insulin upon the glucagon response to a rise and fall of glucose concentration, pancreata isolated from normal rats were perfused with either a potent anti-pork insulin guinea pig serum or a nonimmune guinea pig serum for 30 min. During this period glucose concentration was changed from 100 mg/dl to either 130, 180 or 80 mg/dl for 10 min. Antiserum perfusion at 100 mg/dl caused an approximately two-fold increase in glucagon which was not suppressed by an increase in glucose concentration to either 130 or 180 mg/dl, although glucagon secretion was significantly suppressed in the control experiments in which nonimmune serum was perfused. However, the 0.38 +/- 0.21 ng/min rise in glucagon secretion in response to a reduction in glucose concentration to 80 mg/dl in the control experiments was not abolished by antiserum perfusion but, instead, was enhanced (2.66 +/- 0.60 ng/min). These findings suggest that insulin may be required for glucose-mediated suppression of glucagon in the isolated pancreas of normal rats but not for stimulation of glucagon secretion by mild glucopenia. Alternatively, neutralization of insulin-mediated release-inhibition of glucagon secretion may simply have altered alpha cell responsiveness in a direction that desensitized it nonspecifically to suppression and sensitized it to stimulation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3910495     DOI: 10.1007/bf00291074

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  The in vitro perfused pancreas.

Authors:  G M Grodsky; R E Fanska
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

Authors:  W A Müller; G R Faloona; E Aguilar-Parada; R H Unger
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

4.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

5.  Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas.

Authors:  A Hisatomi; H Maruyama; L Orci; M Vasko; R H Unger
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 6.  Acute effects of insulin on cardiovascular function and noradrenaline uptake and release.

Authors:  N J Christensen
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

7.  Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man.

Authors:  J W Rowe; J B Young; K L Minaker; A L Stevens; J Pallotta; L Landsberg
Journal:  Diabetes       Date:  1981-03       Impact factor: 9.461

8.  The effect of experimental insulin deficiency on glucagon secretion.

Authors:  W A Müller; G R Faloona; R H Unger
Journal:  J Clin Invest       Date:  1971-09       Impact factor: 14.808

9.  Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.

Authors:  G Bolli; P De Feo; G Perriello; S De Cosmo; P Compagnucci; F Santeusanio; P Brunetti; R H Unger
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

10.  Reversal of D- and A-cell insensitivity to glucose in alloxan-diabetic dogs by treatment with the artificial beta cell (Biostator).

Authors:  K Hermansen; O Schmitz; H Orskov
Journal:  Diabetes       Date:  1985-03       Impact factor: 9.461

View more
  6 in total

1.  Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.

Authors:  J Schirra; K Sturm; P Leicht; R Arnold; B Göke; M Katschinski
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

2.  The anterograde and retrograde infusion of glucagon antibodies suggests that A cells are vascularly perfused before D cells within the rat islet.

Authors:  J I Stagner; E Samols; V Marks
Journal:  Diabetologia       Date:  1989-03       Impact factor: 10.122

3.  Effect of monoclonal antibodies to enteroglucagon on ileal adaptation after proximal small bowel resection.

Authors:  M Gregor; H Menge; R Stössel; E O Riecken
Journal:  Gut       Date:  1987       Impact factor: 23.059

4.  Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia.

Authors:  N J Sund; M Z Vatamaniuk; M Casey; S L Ang; M A Magnuson; D A Stoffers; F M Matschinsky; K H Kaestner
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

5.  Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function.

Authors:  Xi Chen; Enrique Maldonado; Ralph A DeFronzo; Devjit Tripathy
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

6.  Direct Effects of D-Chiro-Inositol on Insulin Signaling and Glucagon Secretion of Pancreatic Alpha Cells.

Authors:  Agnese Filippello; Alessandra Scamporrino; Stefania Di Mauro; Roberta Malaguarnera; Antonino Di Pino; Roberto Scicali; Francesco Purrello; Salvatore Piro
Journal:  Biomolecules       Date:  2020-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.